BioNote, Inc. (KRX:377740)

South Korea flag South Korea · Delayed Price · Currency is KRW
5,650.00
+70.00 (1.25%)
Last updated: Dec 19, 2025, 1:07 PM KST
15.90%
Market Cap572.69B
Revenue (ttm)115.09B
Net Income (ttm)117.65B
Shares Out101.36M
EPS (ttm)1,160.97
PE Ratio4.87
Forward PEn/a
Dividend200.00 (3.58%)
Ex-Dividend Daten/a
Volume29,336
Average Volume45,754
Open5,640.00
Previous Close5,580.00
Day's Range5,590.00 - 5,660.00
52-Week Range4,150.00 - 6,320.00
Beta0.94
RSI52.84
Earnings DateFeb 24, 2026

About BioNote

BioNote, Inc., manufactures and sells in-vitro diagnostic animal medicines in South Korea. It offers animal diagnostics products, such as fluorescence immunoassay, molecular diagnostics, clinical biochemistry, rapid immunoassay, and enzyme-linked immunosorbent assay products. The company also provides bio-content products, including rapid immunoassay for humans, human intermediate goods, and bio-contents reagents. In addition, it engages in the production and sell of medical devices. BioNote, Inc. was founded in 2003 and is headquartered in Hwa... [Read more]

Sector Healthcare
Founded 2003
Employees 298
Stock Exchange Korea Stock Exchange
Ticker Symbol 377740
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.